28
Wed, Jun

Bald men are three times as likely to get prostate cancer, Canadian study finds

Health
Typography

I found this interesting and want to share with the Men. According to this new study from the University of Toronto, baldness in men has a strong correlation with the risk of developing prostate cancer.

Studies have already determined a few known risk factors for prostate cancer including advancing age, family history and certain genetic markers. But the connection between male pattern baldness and prostate cancer is a more recent finding, with researchers attributing the link to high testosterone levels.

The new study involved 394 men with no past history of prostate cancer who underwent a biopsy screening at the Princess Margaret hospital in Toronto, with the men being scored on a modified version of the Norwood scale for baldness – a well-used ranking of baldness that runs from one to seven (researchers scored the men’s hair loss on a scale from one to five). The researchers found that male pattern baldness represents a “strong and independent risk factor” for prostate cancer and that the higher the grade of baldness, the higher the risk of developing prostate cancer.

“We were trying to be a bit provocative (about the genetic tests), but it’s true,” said Dr. Neil Fleshner, head of urology at Toronto’s Princess Margaret Cancer Centre and co-author of the study published in the Canadian Urological Association Journal. “If you get it (baldness) early and you get a lot of it, those people are particularly at risk.”

Prostate cancer represents 21 per cent of all new cancers in men and is the third leading cause of death from cancer in men, according to the Canadian Cancer Society.

Prostate cancer involves the abnormal growth of cells of the prostate and manifests through symptoms such as difficulty or pain when urinating or ejaculating, frequent need to urinate and blood in the urine or semen.

BLOG COMMENTS POWERED BY DISQUS
Sign up via our free email subscription service to receive notifications when new information is available.